Local Institution - 0180

Nanjing, Jiangsu 210029

1 studies enrolling now · 2 studies all time

What they study most

Bipolar Disorder Type I With Mania, Relapsed or Refractory Multiple Myeloma

Studies at this site

• A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3) — Recruiting now
• A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) — Running, not enrolling